[Composition of microorganism community in the airways of patients with chronic obstructive pulmonary disease].

This review summarizes results of research on the composition of microorganism community in the airways of patients with chronic obstructive pulmonary disease. Modern technologies for molecular genetic identification of microorganisms provide a deep insight into the microbiota of patients with chronic broncho-obstructive diseases for the better understanding of bronchopulmonary pathology in man and effect of microbiotic communities on the clinical course of diseases and formation of resistance to antibiotics.

[Scanning electron microscopy of peripheral blood erythrocytes in the diagnosis and treatment of hemorrhagic vasculitis in children]. / Metod skaniruiushchei élektronnoi mikroskopii éritrotsitov perifericheskoi krovi v diagnostike i lechenii gemorragicheskogo vaskulita u detei.

Twenty-four children aged 3-15 years were examined, 16 of these with cutaneous and articulo-cutaneous hemorrhagic vasculitis (HV) and 8 normal controls. The patients were divided into 2 groups: 10 patients treated by basic therapy and 6 children whose treatment protocols were supplemented by membranoprotector locheine. The children were repeatedly examined 1 month after discharge from hospital. Scanning electron microscopy of peripheral blood erythrocytes provides valuable diagnostic data on erythrocyte membrane morphology and function in children with HV and can serve as a method for monitoring the efficiency of new approaches to therapy of this disease.

[Mathematical assessment of the effectiveness of treatment for opisthorchiasis in children]. / Matematicheskaia otsenka éffektivnosti lecheniia opistorkhoza u detei. Coobshchenie I.

Presents a quantitative method for analyzing the time course of opisthorchiasis treatment in children based on the exponential model of adult species death during exposure to various anthelminthics. This method permits calculation of the length of elimination of Opisthorchis from the host body in relation to anthelminthic dose; the results of its experimental and clinical trials are presented.